Affinage

PPL

Periplakin · UniProt O60437

Round 2 corrected
Length
1756 aa
Mass
204.7 kDa
Annotated
2026-04-28
54 papers in source corpus 5 papers cited in narrative 5 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

Periplakin is a plakin-family cytolinker protein that localizes to desmosomes and the cornified envelope of stratified squamous epithelia, where it heterodimerizes with envoplakin to scaffold cornified envelope assembly and bridges keratin intermediate filaments to junctional complexes (PMID:9412476). Beyond epithelia, periplakin is a component of the EPPD complex (ezrin, periplakin, periaxin, desmoyokin) at cortex adhaerens junctions of lens fiber cells, contributing to a junctional plaque distinct from the cadherin–catenin complex (PMID:14625392). Periplakin also interacts with the cytoplasmic di-leucine motif of BTN3A1, and this interaction is required for phosphoantigen-dependent activation of Vγ9/Vδ2 γδ T cells, linking the cytoskeleton to innate immune surveillance (PMID:25637025). Periplakin is a target of autoantibodies in paraneoplastic pemphigus (PMID:10379702).

Mechanistic history

Synthesis pass · year-by-year structured walk · 4 steps
  1. 1997 High

    Identification of periplakin as a plakin-family protein that co-immunoprecipitates with envoplakin and localizes to desmosomes in differentiated epidermis established it as a structural scaffold for cornified envelope assembly.

    Evidence cDNA cloning, co-immunoprecipitation, immunogold EM, and confocal microscopy in human keratinocytes

    PMID:9412476

    Open questions at the time
    • No knockout or loss-of-function data to assess essentiality for cornified envelope integrity
    • Stoichiometry and direct binding surfaces of the envoplakin–periplakin heterodimer unresolved
    • No structural model for periplakin domain architecture
  2. 1999 Medium

    Recognition of periplakin as an autoantigen in paraneoplastic pemphigus linked it to an autoimmune blistering disease targeting desmosomal components.

    Evidence Immunoprecipitation and autoantibody profiling of PNP patient sera

    PMID:10379702

    Open questions at the time
    • Single immunological method without demonstration of pathogenic role for anti-periplakin antibodies specifically
    • Whether anti-periplakin autoantibodies are causative or bystander is unknown
  3. 2003 High

    Discovery of periplakin within the EPPD complex at lens fiber cell junctions extended its role beyond keratinizing epithelia, revealing participation in a specialized junctional plaque distinct from the classical cadherin–catenin complex.

    Evidence Reciprocal co-immunoprecipitation and immunolocalization across bovine, porcine, and rat lens tissue

    PMID:14625392

    Open questions at the time
    • Functional consequence of periplakin loss on lens fiber cell architecture not tested
    • Molecular basis of periplakin interaction with periaxin and desmoyokin within the EPPD complex undefined
  4. 2015 High

    Demonstration that periplakin binds the cytoplasmic di-leucine motif of BTN3A1 and that this interaction is required for phosphoantigen-dependent Vγ9/Vδ2 γδ T cell activation revealed an unexpected role for a structural cytolinker in innate immune sensing.

    Evidence Yeast two-hybrid screen, BTN3A1-knockdown and rescue with wild-type versus periplakin-binding-deficient BTN3A1, co-culture γδ T cell activation assays

    PMID:25637025

    Open questions at the time
    • Mechanism by which periplakin facilitates BTN3A1-mediated antigen presentation (e.g., clustering, trafficking, cytoskeletal anchoring) not elucidated
    • Whether periplakin knockdown alone abrogates γδ T cell activation not directly shown
    • Structural basis of the periplakin–BTN3A1 interaction unresolved

Open questions

Synthesis pass · forward-looking unresolved questions
  • A unifying model of how periplakin's cytolinker and immune functions are coordinated — and whether periplakin is essential in vivo for either epithelial integrity or γδ T cell immunity — remains to be established.
  • No periplakin-knockout animal phenotype reported in this literature
  • No high-resolution structure of periplakin or its complexes
  • Potential redundancy with envoplakin or other plakins not addressed

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0005198 structural molecule activity 3 GO:0008092 cytoskeletal protein binding 3
Localization
GO:0005856 cytoskeleton 2 GO:0005886 plasma membrane 2
Pathway
R-HSA-168256 Immune System 1
Complex memberships
EPPD complex

Evidence

Reading pass · 5 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1997 Periplakin (PPL) was identified as a novel 195 kDa member of the plakin family of cytolinker proteins that becomes incorporated into the cornified envelope of epidermal keratinocytes. It is expressed in keratinizing and non-keratinizing stratified squamous epithelia, associates with desmosomal plaques and keratin filaments in differentiated epidermis, and co-immunoprecipitates with envoplakin. Confocal microscopy revealed that envoplakin and periplakin form a network radiating from desmosomes, suggesting they provide a scaffolding for cornified envelope assembly. cDNA sequencing, immunogold electron microscopy, co-immunoprecipitation, confocal immunofluorescence microscopy The Journal of cell biology High 9412476
2002 Periplakin is established as a member of the plakin family of cytolinker proteins that connect cytoskeletal elements (microfilaments, microtubules, intermediate filaments) to each other and to junctional complexes including desmosomes and cell-adhesion molecules, and participates in domain-based interactions with armadillo family members. Dysfunction of plakin family members including periplakin is involved in inherited and autoimmune diseases affecting skin, neuronal tissue, and muscle. Review synthesizing domain interaction data and genetic/disease evidence Trends in cell biology Medium 11854008
1999 Periplakin was identified as one of the plakin family members (together with desmoplakin, BPAG1, envoplakin, and plectin) targeted by autoantibodies in paraneoplastic pemphigus (PNP), establishing it as a cytoplasmic structural component recognized in autoimmune disease. Immunoprecipitation and autoantibody profiling in PNP patient sera Journal of dermatological science Medium 10379702
2003 Periplakin was identified as a component of the EPPD complex (ezrin, periplakin, periaxin, desmoyokin) in lens fiber cell cortex adhaerens junctions, where it participates together with moesin, spectrin(s) and plectin in a distinct junctional plaque ensemble on the long sides of lens fiber hexagons, separate from the cadherin-catenin complex. Biochemical fractionation, immunoprecipitation, immunolocalization microscopy across multiple species (cow, pig, rat) Journal of cell science High 14625392
2015 Periplakin interacts with the cytoplasmic tail of BTN3A1 at a membrane-proximal di-leucine motif proximal to the B30.2 domain, an interaction identified by yeast two-hybrid and confirmed functionally. Re-expression of wild-type BTN3A1 but not a periplakin-binding-deficient variant (BTN3A1Δexon5) into a BTN3A1 knockdown line restored γδ T cell responses, demonstrating that periplakin interaction is required for BTN3A1-mediated phosphoantigen presentation and Vγ9/Vδ2 T cell activation, thereby linking the cytoskeleton to innate immune surveillance. Yeast two-hybrid, knockdown cell lines, re-expression rescue assays, co-culture γδ T cell activation assays Journal of immunology High 25637025

Source papers

Stage 0 corpus · 54 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2002 Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proceedings of the National Academy of Sciences of the United States of America 1479 12477932
2004 Large-scale characterization of HeLa cell nuclear phosphoproteins. Proceedings of the National Academy of Sciences of the United States of America 1159 15302935
2015 The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell 1118 26186194
2017 Architecture of the human interactome defines protein communities and disease networks. Nature 1085 28514442
2015 A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell 1015 26496610
2014 A proteome-scale map of the human interactome network. Cell 977 25416956
2020 A reference map of the human binary protein interactome. Nature 849 32296183
2018 VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation. Cell discovery 829 29507755
2021 Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. Cell 705 33961781
2011 Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Briefings in bioinformatics 656 21873635
2006 A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 610 16713569
2008 Large-scale proteomics and phosphoproteomics of urinary exosomes. Journal of the American Society of Nephrology : JASN 607 19056867
2002 Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. The Journal of biological chemistry 557 12176997
2010 Systematic analysis of human protein complexes identifies chromosome segregation proteins. Science (New York, N.Y.) 421 20360068
2015 Panorama of ancient metazoan macromolecular complexes. Nature 407 26344197
1996 Normalization and subtraction: two approaches to facilitate gene discovery. Genome research 401 8889548
2007 Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS genetics 325 17500595
2010 Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics. Cell 318 21145461
2006 Phosphoproteome analysis of the human mitotic spindle. Proceedings of the National Academy of Sciences of the United States of America 281 16565220
2002 Plakins: a family of versatile cytolinker proteins. Trends in cell biology 251 11854008
2004 Functional proteomics mapping of a human signaling pathway. Genome research 247 15231748
2009 Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). Journal of proteome research 237 19199708
2013 Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? The EMBO journal 213 23314748
1997 Periplakin, a novel component of cornified envelopes and desmosomes that belongs to the plakin family and forms complexes with envoplakin. The Journal of cell biology 179 9412476
2014 E-cadherin interactome complexity and robustness resolved by quantitative proteomics. Science signaling 162 25468996
1998 Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA research : an international journal for rapid publication of reports on genes and genomes 156 9628581
1999 Autoimmunity against desmosomal cadherins in pemphigus. Journal of dermatological science 135 10379702
2015 Activation of human γδ T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin. Journal of immunology (Baltimore, Md. : 1950) 126 25637025
2010 Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. Molecular medicine (Cambridge, Mass.) 108 20379614
2003 A novel cell-cell junction system: the cortex adhaerens mosaic of lens fiber cells. Journal of cell science 101 14625392
2019 Immobilization of porcine pancreatic lipase onto a metal-organic framework, PPL@MOF: A new platform for efficient ligand discovery from natural herbs. Analytica chimica acta 53 31986282
2017 Fabrication of chitosan-mesoporous silica SBA-15 nanocomposites via functional ionic liquid as the bridging agent for PPL immobilization. Carbohydrate polymers 28 29279121
1991 Cloning, genetic analysis, and nucleotide sequence of a determinant coding for a 19-kilodalton peptidoglycan-associated protein (Ppl) of Legionella pneumophila. Infection and immunity 24 1855972
2015 4-Hydroxy-2-nonenal (4-HNE) and Its Lipation Product 2-Pentylpyrrole Lysine (2-PPL) in Peanuts. Journal of agricultural and food chemistry 20 25945920
2014 Heterologous expression of a lectin from Pleurocybella porrigens (PPL) in Phanerochaete sordida YK-624. Journal of microbiological methods 17 24631556
2008 Alternate arrangement of PpL B3 domain and SpA D domain creates synergistic double-site binding to VH3 and Vkappa regions of fab. DNA and cell biology 16 18694300
2017 In Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse Potential. Frontiers in psychiatry 15 28446883
1995 Cloning, expression and purification of Ppl-1, a kappa-chain binding protein, based upon protein L from Peptostreptococcus magnus. Bioseparation 14 8767928
2000 Technology evaluation: transgenic alpha-1-antitrypsin (AAT), PPL therapeutics. Current opinion in molecular therapeutics 13 11249642
1990 [Effect of a new 10% hydroxyethyl starch solution HES/270/0.5 on blood coagulation, blood loss and hemodynamics in comparison with 3.5% PPL]. Infusionstherapie (Basel, Switzerland) 9 1709146
1993 Isolation and characterisation of a CDw50 negative Jurkat T-cell line variant (PPL.1). Leukemia research 8 8429685
2012 Effects of microvascular density on primary pulmonary non-Hodgkin's lymphoma (PPL). Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 7 22875783
2019 Writing Behavior of Phospholipids in Polymer Pen Lithography (PPL) for Bioactive Micropatterns. Polymers 6 31096642
2013 Employing MCMC under the PPL framework to analyze sequence data in large pedigrees. Frontiers in genetics 6 23626600
2022 More Than Meets the Kappa for Antibody Superantigen Protein L (PpL). Antibodies (Basel, Switzerland) 4 35225872
2021 Downregulation of lncRNA PpL-T31511 and Pp-miRn182 Promotes Hydrogen Cyanamide-Induced Endodormancy Release through the PP2C-H2O2 Pathway in Pear (Pyrus pyrifolia). International journal of molecular sciences 4 34769273
2023 The VASCERN PPL working group patient pathway for primary and paediatric lymphoedema. European journal of medical genetics 3 38143023
2025 The opioid partial agonist PPL-138 reduces alcohol self-administration in rats susceptible to post-traumatic stress disorder. British journal of pharmacology 2 40782008
2022 PPL-103: A mixed opioid partial agonist with desirable anti-cocaine properties. Progress in neuro-psychopharmacology & biological psychiatry 2 35798174
2026 Assessment of tissue homogenate levels of TGM1, PPL and KRT8 in a group of patients with HNSCC tumors and matched surgical margin samples. Frontiers in oncology 0 41695373
2025 Crystal and Cryo-EM structure of PPL, a novel hexameric R-type lectin from the poisonous mushroom Pleurocybella porrigens. Glycobiology 0 41342409
2025 The Ppl protein senses 3'-hydroxyl DNA overhangs and NTP depletion to halt phage infection. Molecular cell 0 41344330
1981 [Changes in Bacillus pumilus antibiotic activity and sensitivity with integration and disintegration of plasmid pPL 7065]. Antibiotiki 0 7305314
1980 [Integration of plasmid pPL 7065 into chromosome of Bac. pumilis]. Biokhimiia (Moscow, Russia) 0 7213833